로딩 중…
지수 로딩 중…
LENZ Therapeutics, Inc.
LENZ· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.15-3.00%
2026-06-18
Price Chart
LENZ Therapeutics, Inc.-79.52%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $193M |
| Revenue | $21M |
| Net Income | $-109M |
| Total Assets | $273M |
| Net Assets | $246M |
| Value | |
| P/B | 0.78x |
| P/S | 9.19x |
| FCF Yield | -45.34% |
| Profitability | |
| ROE | -44.22% |
| ROA | -39.99% |
| Op. Margin | -563.83% |
| Financial Health | |
| Debt Ratio | 10.57% |
| Total Debt | $237000.00 |
| FCF | $-87M |
| Cash | $25M |
| Current Ratio | 10.40x |
| Performance | |
| 1Y Return | -79.52% |
| 1M Return | -7.52% |
| From 52W High | -87.80% |
| 1Y MDD | -87.46% |
| Trading | |
| Volume | 1,111,563 shares |
| Trading Value | $7M |
| Per Share | |
| EPS | $-1.62 |
| BPS | $6.79 |